皓元医药:24 年业绩稳增,25 年共创未来

和讯网
28 Feb

【2 月 28 日,皓元医药(688131.SH)披露业绩快报】 2024 年,该公司实现营收 22.58 亿元,同比增长 20.09%;归属于母公司所有者的净利润为 2.05 亿元,同比增长 60.83%。 2024 年,全球生物医药行业迎来关键转折,皓元医药紧抓行业机遇,通过业务协同实现全链条价值释放。前端生命科学试剂业务增长强劲,收入占比提高,品牌具国际影响力。后端专注高难、高技术壁垒...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10